Symbol="ATOS"
AssetType="Common Stock"
Name="Atossa Genetics Inc"
Description="Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington."
CIK="1488039"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SURGICAL & MEDICAL INSTRUMENTS & APPARATUS"
Address="2345 EASTLAKE AVENUE EAST, SUITE 201, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="103911000"
EBITDA="-31224000"
PERatio="None"
PEGRatio="0"
BookValue="0.824"
DividendPerShare="0"
DividendYield="0"
EPS="-0.24"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.161"
ReturnOnEquityTTM="-0.269"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4.63"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.627"
EVToRevenue="-"
EVToEBITDA="2.557"
Beta="1.225"
num_52WeekHigh="1.39"
num_52WeekLow="0.5"
num_50DayMovingAverage="1.053"
num_200DayMovingAverage="0.82"
SharesOutstanding="125785000"
DividendDate="2018-04-20"
ExDividendDate="None"
symbol="ATOS"
open="0.84"
high="0.84"
low="0.77"
price="0.79"
volume="841213.00"
latest_trading_day="2023-08-31"
previous_close="0.83"
change="-0.04"
change_percent="-4.3820%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="35"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="744315"
Change_recent_avg="0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.52"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="1165"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0199.jpeg"
image_negative_thumbnail_id_2="107"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0069.jpeg"
image_neutral_thumbnail_id_1="551"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_neutral_thumbnail_id_2="593"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_positive_thumbnail_id_1="666"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0042.jpeg"
image_positive_thumbnail_id_2="655"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0053.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
